Literature DB >> 7607344

Histopathology of diabetic retinopathy in man.

A Garner1.   

Abstract

The retinal changes associated with diabetes mellitus are a consequence of the systemic microangiopathy with modifications related to the intraocular environment. The vascular disorders underlying background retinopathy are arteriolar hyalinosis (which together with abnormalities in the circulating blood can give rise to focal capillary closure), venular dilatation, and capillaropathy in the form of pericyte degeneration, basement membrane thickening and microaneurysm formation. Retinal complications consist of plasma exudation and punctate haemorrhages. Maculopathy is due to cystoid oedema. Increasing closure of capillaries is linked with cotton-wool spots and intraretinal microvascular anomalies, the former reflecting a consequence and the latter a response to increased ischaemia. Vascular proliferation in front of the retina originates from venules close to areas of ischaemia; the endothelium may be fenestrated initially and fibrosis may accompany the new vessels.

Entities:  

Mesh:

Year:  1993        PMID: 7607344     DOI: 10.1038/eye.1993.58

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  43 in total

1.  The pathogenesis of diabetic retinopathy.

Authors:  M R Stanford
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

2.  In vivo adaptive optics microvascular imaging in diabetic patients without clinically severe diabetic retinopathy.

Authors:  Stephen A Burns; Ann E Elsner; Toco Y Chui; Dean A Vannasdale; Christopher A Clark; Thomas J Gast; Victor E Malinovsky; Anh-Danh T Phan
Journal:  Biomed Opt Express       Date:  2014-02-27       Impact factor: 3.732

3.  Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy.

Authors:  G A Limb; A H Chignell; W Green; F LeRoy; D C Dumonde
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

4.  Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy?

Authors:  Jennifer T Durham; Brian M Dulmovits; Stephen M Cronk; Anthony R Sheets; Ira M Herman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

5.  Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.

Authors:  G A Limb; L Webster; H Soomro; S Janikoun; J Shilling
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 6.  From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy.

Authors:  Joseph F Arboleda-Velasquez; Cammi N Valdez; Christina K Marko; Patricia A D'Amore
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

7.  Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina.

Authors:  E J Kuiper; A N Witmer; I Klaassen; N Oliver; R Goldschmeding; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

Review 8.  An Overview of Our Current Understanding of Diabetic Macular Ischemia (DMI).

Authors:  Muhammad Usman
Journal:  Cureus       Date:  2018-07-30

9.  Effect of diabetes on transscleral delivery of celecoxib.

Authors:  Narayan P S Cheruvu; Aniruddha C Amrite; Uday B Kompella
Journal:  Pharm Res       Date:  2008-11-06       Impact factor: 4.200

10.  Morphological and immunocytochemical analysis of human retinal glia subtypes in vitro.

Authors:  Shao-Fen Lin; Yu-Xiang Mao; Bin Li; Wei Sun; Shi-Bo Tang
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.